Annovis Bio, Inc. (ANVS) shareholders
Close on Nov 17, 2026Market cap $31.66MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 2,775,578 | 6.10% | 13G (passive) | Jun 30, 2026 |
| Empery Asset Management, LP Joint filing with Ryan M. Lane (5.64%) | 2,401,476 | 5.64% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ANVS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 2,401,476 | 5.64% | $4.47M | New | 5.17% |
| Marshall Wace, Llp | 1,842,339 | 4.32% | $3.43M | +654,840 | 0.00% |
| Vanguard Capital Management LLC | 1,647,322 | 3.87% | $3.06M | +774,941 | 0.00% |
| Tudor Investment Corp Et Al | 1,357,134 | 3.19% | $2.52M | New | 0.00% |
| Renaissance Technologies LLC | 1,002,200 | 2.35% | $1.86M | +654,600 | 0.00% |
| Two Sigma Investments, LP | 579,571 | 1.36% | $1.08M | −48,088 | 0.00% |
| Geode Capital Management, LLC | 283,817 | 0.67% | $528.13K | +36,304 | 0.00% |
| BlackRock, Inc. | 249,856 | 0.59% | $464.73K | +110,323 | 0.00% |
| Citadel Advisors LLC | 243,682 | 0.57% | $453.25K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 177,530 | 0.42% | $330.21K | +45,488 | 0.00% |
| Susquehanna International Group, Llp | 146,804 | 0.34% | $273.06K | −71,532 | 0.00% |
| Quadrature Capital Ltd | 90,884 | 0.21% | $169.04K | New | 0.00% |
| State Street Corp | 77,735 | 0.18% | $144.59K | – | 0.00% |
| Northern Trust Corp | 68,070 | 0.16% | $126.61K | −73,660 | 0.00% |
| First National Trust Co | 60,000 | 0.14% | $111.60K | +20,000 | 0.00% |
| Sherry Group, Inc. | 57,270 | 0.13% | $106.52K | – | 0.10% |
| Gsa Capital Partners Llp | 49,904 | 0.12% | $93.00K | +4,481 | 0.01% |
| Greenwich Wealth Management LLC | 48,400 | 0.11% | $90.00K | +1,400 | 0.00% |
| Headlands Technologies LLC | 48,071 | 0.11% | $89.41K | New | 0.01% |
| Wescott Financial Advisory Group, LLC | 41,607 | 0.10% | $77.39K | – | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 61 | 11M | 25.5% | 16 / 18 | 6 / 11 | 7M | 0M |
| Q1 2026 | 56 | 5M | 11.1% | 14 / 13 | 10 / 9 | 2M | 1M |
| Q4 2025 | 53 | 4M | 9.9% | 20 / 17 | 3 / 8 | 3M | 0M |
| Q3 2025 | 42 | 2M | 4.8% | 5 / 11 | 8 / 5 | 0M | 0M |
| Q2 2025 | 42 | 2M | 4.3% | 10 / 12 | 6 / 12 | 0M | 1M |
| Q1 2025 | 44 | 2M | 4.9% | 13 / 16 | 4 / 8 | 1M | 0M |
| Q4 2024 | 40 | 2M | 3.7% | 9 / 13 | 9 / 4 | 1M | 0M |
| Q3 2024 | 35 | 1M | 2.8% | 12 / 11 | 4 / 7 | 0M | 0M |
| Q2 2024 | 31 | 1M | 2.3% | 6 / 8 | 8 / 6 | 0M | 0M |
| Q1 2024 | 31 | 1M | 2.9% | 6 / 12 | 6 / 10 | 0M | 0M |
| Q4 2023 | 36 | 1M | 2.8% | 11 / 10 | 7 / 5 | 0M | 0M |
| Q3 2023 | 30 | 1M | 2.6% | 3 / 6 | 9 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
14 funds held ANVS in Q2 2026, 86% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ANVS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,219,718 | 2.86% | $2.27M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 393,887 | 0.92% | $732.63K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 123,461 | 0.29% | $237.05K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 103,332 | 0.24% | $192.20K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 34,459 | 0.08% | $66.16K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 33,577 | 0.08% | $62.45K | 0.04% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 33,419 | 0.08% | $64.16K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 20,994 | 0.05% | $39.05K | 0.00% | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 12,723 | 0.03% | $23.66K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 6,991 | 0.02% | $13.00K | 0.01% | Jun 30, 2026 |
| Total Stock Market Index Trust | 557 | 0.00% | $1.04K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Maria-Luisa Maccecchini | President & CEO, Director | 1,212,020 | 2.84% | Nov 12, 2025 |
| Andrew Walsh | Vice President, Finance | 500 | 0.00% | Jun 18, 2025 |
| Michael B. Hoffman | Director | 8,588,240 | 20.16% | Nov 6, 2026 |
| Claudine Bruck | Director | 13,709 | 0.03% | Nov 12, 2025 |
| Reid McCarthy | Director | 9,305 | 0.02% | Jun 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael B. Hoffman Director | Nov 6, 2026 | Buy | +5,000,000 | $1.00 | $5.00M | 8,364,883 |
| Michael B. Hoffman Director | May 20, 2026 | Buy | +18,849 | $1.80 | $33.93K | 3,309,950 |
| Michael B. Hoffman Director | May 20, 2026 | Buy | +2,562 | $1.75 | $4.48K | 3,291,101 |
| Michael B. Hoffman Director | May 20, 2026 | Buy | +54,933 | $1.90 | $104.37K | 3,364,883 |
| Michael B. Hoffman Director | Apr 2, 2026 | Buy | +713,800 | $2.10 | $1.50M | 3,288,539 |
| Michael B. Hoffman Director | Dec 8, 2025 | Buy | +30,000 | $4.34 | $130.20K | 2,559,739 |
| Michael B. Hoffman Director | Dec 8, 2025 | Buy | +15,000 | $4.24 | $63.60K | 2,574,739 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +9,200 | $3.85 | $35.42K | 2,501,228 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +415 | $4.14 | $1.72K | 2,501,643 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +28,096 | $4.15 | $116.60K | 2,529,739 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +1,489 | $4.13 | $6.15K | 2,492,028 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +1,489 | $4.13 | $6.15K | 2,482,028 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +9,200 | $3.85 | $35.42K | 2,491,228 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +415 | $4.14 | $1.72K | 2,491,643 |
| Michael B. Hoffman Director | Nov 24, 2025 | Buy | +28,096 | $4.15 | $116.60K | 2,519,739 |
| Michael B. Hoffman Director | Nov 21, 2025 | Buy | +10,000 | $3.50 | $35.00K | 2,490,539 |
| Michael B. Hoffman Director | Nov 21, 2025 | Buy | +10,000 | $3.49 | $34.90K | 2,480,539 |
| Michael B. Hoffman Director | Nov 14, 2025 | Buy | +15,000 | $2.11 | $31.65K | 2,470,539 |
| Michael B. Hoffman Director | Oct 28, 2025 | Buy | +975,610 | $2.05 | $2.00M | 2,455,539 |
| Maria-Luisa Maccecchini President & CEO, Director | Oct 28, 2025 | Buy | +97,561 | $2.05 | $200.00K | 1,212,020 |
| Claudine Bruck Director | Sep 10, 2025 | Option exercise | +7,142 | $0.14 | $1,000 | 13,709 |
| Michael B. Hoffman Director | Aug 29, 2025 | Award | +5,000 | $2.28 | $11.40K | 1,469,929 |
| Michael B. Hoffman Director | Aug 29, 2025 | Award | +5,000 | $2.29 | $11.45K | 1,474,929 |
| Michael B. Hoffman Director | Aug 29, 2025 | Award | +5,000 | $2.30 | $11.50K | 1,479,929 |
| Michael B. Hoffman Director | Aug 19, 2025 | Award | +1,100 | $2.57 | $2.83K | 1,464,929 |
| Michael B. Hoffman Director | Aug 19, 2025 | Award | +6,717 | $2.60 | $17.46K | 1,453,001 |
| Michael B. Hoffman Director | Aug 19, 2025 | Award | +5,283 | $2.59 | $13.68K | 1,458,284 |
| Michael B. Hoffman Director | Aug 19, 2025 | Award | +5,545 | $2.58 | $14.31K | 1,463,829 |
| Andrew Walsh Vice President, Finance | Jun 16, 2025 | Award | +500 | $2.90 | $1.45K | 500 |
| Michael B. Hoffman Director | Jun 13, 2025 | Award | +25,000 | $2.80 | $70.00K | 1,446,283 |
| Michael B. Hoffman Director | Jun 13, 2025 | Award | +1 | $2.83 | $3 | 1,446,284 |
| Reid McCarthy Director | Jun 10, 2025 | Award | +2,000 | $2.95 | $5.90K | 9,305 |
| Maria-Luisa Maccecchini President & CEO, Director | Jun 4, 2025 | Award | +46,000 | $3.37 | $155.02K | 1,114,459 |
| Michael B. Hoffman Director | May 29, 2025 | Award | +5,000 | $2.43 | $12.15K | 1,421,283 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Mar 31, 2024 | Gift | −10,000 | – | – | 1,068,459 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Mar 31, 2024 | Gift | −10,000 | – | – | 1,078,459 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Mar 28, 2024 | Gift | −10,000 | – | – | 1,088,459 |
| Claudine Bruck Director | Nov 20, 2023 | Other | +0 | – | – | 6,567 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Nov 20, 2023 | Award | +40,970 | $6.10 | $249.92K | 1,098,459 |
| Michael B. Hoffman Director, 10% owner | Nov 20, 2023 | Award | +163,880 | $6.10 | $999.67K | 223,357 |
| Reid McCarthy Director | Nov 20, 2023 | Other | +0 | – | – | 7,305 |
| Henry Hagopian III Chief Financial Officer | Nov 20, 2023 | Award | +820 | $6.10 | $5.00K | 1,820 |
| Mark K. White Director | Nov 20, 2023 | Award | +1,990 | $6.10 | $12.14K | 61,167 |
| Mark K. White Director | Nov 20, 2023 | Award | +2,000 | $6.07 | $12.14K | 61,177 |
| Claudine Bruck Director | Nov 20, 2023 | Award | +1,000 | $6.07 | $6.07K | 7,567 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Nov 20, 2023 | Award | +41,186 | $6.07 | $250.00K | 1,098,675 |
| Reid McCarthy Director | Nov 20, 2023 | Award | +824 | $6.07 | $5.00K | 8,129 |
| Michael B. Hoffman Director, 10% owner | Nov 20, 2023 | Award | +164,745 | $6.07 | $1.00M | 224,222 |
| Henry Hagopian III Chief Financial Officer | Nov 20, 2023 | Award | +824 | $6.07 | $5.00K | 1,824 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Apr 24, 2023 | Gift | −3,000 | – | – | 1,057,489 |
| Mark K. White Director | Apr 7, 2023 | Award | +3,000 | $12.61 | $37.83K | 59,177 |
| Henry Hagopian III Chief Financial Officer | Apr 7, 2023 | Award | +1,000 | $12.61 | $12.61K | 1,000 |
| Michael B. Hoffman Director, 10% owner | Apr 7, 2023 | Award | +59,477 | $12.61 | $750.00K | 59,477 |
| Reid McCarthy Director | Apr 7, 2023 | Award | +476 | $12.61 | $6.00K | 7,305 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Apr 7, 2023 | Award | +20,000 | $12.61 | $252.20K | 1,060,489 |
| Claudine Bruck Director | Apr 7, 2023 | Award | +500 | $12.61 | $6.31K | 6,567 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Feb 6, 2023 | Option exercise | +52,755 | $0.14 | $7.39K | 1,040,489 |
| Maria-Luisa Maccecchini President and CEO, Director, 10% owner | Jan 14, 2022 | Option exercise | +32,959 | $0.14 | $4.61K | 987,734 |
| Michael B. Hoffman Director, 10% owner | Jan 4, 2022 | Option exercise | +30,000 | $4.39 | $131.70K | 1,415,889 |
| Michael B. Hoffman Director, 10% owner | Jan 4, 2022 | Tax withholding | −6,658 | $19.78 | $131.70K | 1,409,231 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Annovis Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 33,649 shares on Sep 11, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Mark K. White Director | Apr 2, 2026 | 7,142 | $14.85K | Apr 2, 2026 | Option Exercise |
See a number that looks wrong?